Statements of Shareholders' Equity (Deficiency) - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total BioLife Solutions, Inc. Shareholders' Equity/Deficiency	Non-Controlling Interest Equity/Deficiency	Total
Beginning Balance - Shares at Dec. 31, 2013	5,031,336
Beginning Balance - Amount at Dec. 31, 2013	$ 5,030	$ 43,618,686	$ 0	$ (56,895,237)	$ (13,271,521)	$ 0	$ (13,271,521)
Stock-based compensation		229,679			229,679		229,679
Stock issued for services - Shares	74,720
Stock issued for services - Amount	$ 75	209,925			210,000		210,000
Stock option/warrant exercises - Shares	68,520
Stock option/warrant exercises - Amount	$ 69	83,525			83,594		83,594
Stock issued in connection with public registered stock offering March 25, 2014, net of transaction costs - Shares	3,588,878
Stock issued in connection with public registered stock offering March 25, 2014, net of transaction costs - Amount	$ 3,589	13,592,641			13,596,230		13,596,230
Stock issued in connection with conversion of outstanding notes and interest on March 25, 2014, net of unamortized deferred financing costs of $101,852 - Shares	3,321,405
Stock issued in connection with conversion of outstanding notes and interest on March 25, 2014, net of unamortized deferred financing costs of $101,852 - Amount	$ 3,321	14,176,872			14,180,193		14,180,193
Other comprehensive income (loss)			(6,448)		(6,448)		(6,448)
Capital contribution of non-controlling interest in biologistex CCM, LLC joint venture						2,215,385	2,215,385
Net loss				(3,217,750)	(3,217,750)	(83,045)	(3,300,795)
Ending Balance, Shares at Dec. 31, 2014	12,084,859
Ending Balance, Amount at Dec. 31, 2014	$ 12,084	71,911,328	(6,448)	(60,112,987)	11,803,977	2,132,340	13,936,317
Stock-based compensation		511,457			511,457		511,457
Stock option/warrant exercises - Shares	363,532
Stock option/warrant exercises - Amount	$ 363	400,613			400,976		400,976
Other comprehensive income (loss)			5,997		5,997		5,997
Net loss				(4,213,936)	(4,213,936)	(781,440)	(4,995,376)
Ending Balance, Shares at Dec. 31, 2015	12,448,391
Ending Balance, Amount at Dec. 31, 2015	$ 12,447	$ 72,823,398	$ (451)	$ (64,326,923)	$ 8,508,471	$ 1,350,900	$ 9,859,371